Home›Search›Letters in Drug Design and Discovery

Letters in Drug Design and Discovery

Bentham Science Publishers · United Arab Emirates · Est. 1969

ISSN1570-1808eISSN1875-628X

SJR Q3✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.301

H-Indexi

SNIPi

0.402

Total Worksi

3,285

Total Citationsi

17,960

2yr Mean Citednessi

0.68

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Letters in Drug Design and Discovery covers Pharmaceutical Science, Drug Discovery, and Molecular Medicine.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1969

Annual Volume~ 203 articles / year

StatusActive (last: 2026)

Total Publications3,285

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1570-1808 / 1875-628X

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

431

2019

150

737

2020

474

2021

248

1.5k

2022

226

809

2023

110

227

2024

272

347

2025

136

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ3

Pharmaceutical ScienceQ3

Molecular MedicineQ4

Subject Classification

Web of Science Categories

Chemistry, Medicinal

Scopus Categories

Drug DiscoveryPharmaceutical ScienceMolecular Medicine

Research Topics (OpenAlex)

Synthesis and biological activityComputational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic CompoundsClick Chemistry and ApplicationsChemical Synthesis and AnalysisSynthesis and Biological EvaluationSynthesis and Reactions of Organic CompoundsCancer therapeutics and mechanismsPhenothiazines and Benzothiazines Synthesis and ActivitiesCholinesterase and Neurodegenerative Diseases

Frequently asked questions about Letters in Drug Design and Discovery

Is Letters in Drug Design and Discovery a predatory journal?

PubScope has no integrity flags on record for Letters in Drug Design and Discovery: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Letters in Drug Design and Discovery?

Letters in Drug Design and Discovery is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.68.

Is Letters in Drug Design and Discovery indexed in Scopus and Web of Science?

Letters in Drug Design and Discovery is indexed in Web of Science, Scopus.